
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy
Yuan Gao, Caixia Wu, Xueqi Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Yuan Gao, Caixia Wu, Xueqi Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Showing 21 citing articles:
Revolutionizing food science with mass spectrometry imaging: A comprehensive review of applications and challenges
Qing Shen, Shitong Wang, Honghai Wang, et al.
Comprehensive Reviews in Food Science and Food Safety (2024) Vol. 23, Iss. 4
Closed Access | Times Cited: 11
Qing Shen, Shitong Wang, Honghai Wang, et al.
Comprehensive Reviews in Food Science and Food Safety (2024) Vol. 23, Iss. 4
Closed Access | Times Cited: 11
Recent Advances in Mass Spectrometry-Based Spatially Resolved Molecular Imaging of Drug Disposition and Metabolomics
Yu Chen, Ying Liu, Ximei Li, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1273-1283
Open Access | Times Cited: 13
Yu Chen, Ying Liu, Ximei Li, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1273-1283
Open Access | Times Cited: 13
Innovative applications and future trends of multiparametric PET in the assessment of immunotherapy efficacy
Tingting Qiao, Zhaoping Cheng, Yanhua Duan
Frontiers in Oncology (2025) Vol. 14
Open Access
Tingting Qiao, Zhaoping Cheng, Yanhua Duan
Frontiers in Oncology (2025) Vol. 14
Open Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment 18F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer
Mimi Xu, Yafei Zhang, Kui Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Mimi Xu, Yafei Zhang, Kui Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Construction and Preclinical Evaluation of 124I/125I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3
Jinping Tao, Ziqing Zeng, Chengxue He, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 944-956
Closed Access | Times Cited: 4
Jinping Tao, Ziqing Zeng, Chengxue He, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 944-956
Closed Access | Times Cited: 4
Development and evaluation of biphenyl-based small-molecule radiotracers for PET imaging of PD-L1 in tumor
Nan Zhang, Junyi Zhu, Xin Hu, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130187-130187
Closed Access
Nan Zhang, Junyi Zhu, Xin Hu, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130187-130187
Closed Access
The development process of ‘fit-for-purpose’ imaging biomarkers to characterize the tumor microenvironment
Jakoba J. Eertink, Idris Bahce, John C. Waterton, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Jakoba J. Eertink, Idris Bahce, John C. Waterton, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons
William Karlsen, Lin Akily, M. Mierzejewska, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1990-1990
Open Access | Times Cited: 3
William Karlsen, Lin Akily, M. Mierzejewska, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1990-1990
Open Access | Times Cited: 3
Nano-imaging agents for brain diseases: Environmentally responsive imaging and therapy
Fuming Liang, Qing You, Xiaopeng Ma, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13134-13163
Closed Access | Times Cited: 7
Fuming Liang, Qing You, Xiaopeng Ma, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13134-13163
Closed Access | Times Cited: 7
Gold nanorods with iron oxide dual-modal bioprobes in SERS-MRI enable accurate programmed cell death ligand-1 expression detection in triple-negative breast cancer
Ting Pan, Dinghu Zhang, Xiaoxia Wu, et al.
APL Bioengineering (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 6
Ting Pan, Dinghu Zhang, Xiaoxia Wu, et al.
APL Bioengineering (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 6
[18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond
Alberto Miceli, Lorenzo Jonghi-Lavarini, Giulia Santo, et al.
Clinical and Translational Imaging (2023) Vol. 11, Iss. 5, pp. 421-437
Open Access | Times Cited: 6
Alberto Miceli, Lorenzo Jonghi-Lavarini, Giulia Santo, et al.
Clinical and Translational Imaging (2023) Vol. 11, Iss. 5, pp. 421-437
Open Access | Times Cited: 6
A systematic review of gastritis as an immune-related adverse event in clinical interventions
Fei Su, Wenxuan Fan, Yan Zhang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Fei Su, Wenxuan Fan, Yan Zhang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Current Advances in Viral Nanoparticles for Biomedicine
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access | Times Cited: 1
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access | Times Cited: 1
Gallium-68-Labeled ZPDGFRβ Affibody: A Potential PET Probe for Platelet-Derived Growth Factor Receptor β-Expressing Carcinomas
Xin Li, Li Zhao, Mingxing Huang, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 1357-1364
Closed Access | Times Cited: 2
Xin Li, Li Zhao, Mingxing Huang, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 1357-1364
Closed Access | Times Cited: 2
Multimodal Imaging Approach for Tumor Treatment Response Evaluation in the Era of Immunotherapy
Geewon Lee, Seung Hwan Moon, Jong‐Hoon Kim, et al.
Investigative Radiology (2024)
Closed Access
Geewon Lee, Seung Hwan Moon, Jong‐Hoon Kim, et al.
Investigative Radiology (2024)
Closed Access
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
Ingrid J.G. Burvenich, Christian Wichmann, Alexander Franklin McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3863-3873
Open Access
Ingrid J.G. Burvenich, Christian Wichmann, Alexander Franklin McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3863-3873
Open Access
Molecular MR Imaging of T-Cell Immune Response to Cryoablation in Immunologically Hot vs. Cold Hepatocellular Carcinoma.
Jessica Gois Santana, Annabella Shewarega, David Nam, et al.
JHEP Reports (2024) Vol. 7, Iss. 3, pp. 101294-101294
Closed Access
Jessica Gois Santana, Annabella Shewarega, David Nam, et al.
JHEP Reports (2024) Vol. 7, Iss. 3, pp. 101294-101294
Closed Access
PET/CT-guided and OPN-targeted melanin nanoparticle platform for early diagnosis and precision therapy of idiopathic pulmonary fibrosis (IPF)
Jie Ji, Jie Sheng, Pengjun Zhang, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158140-158140
Closed Access
Jie Ji, Jie Sheng, Pengjun Zhang, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158140-158140
Closed Access
Synthesis and Evaluation of Fluorine-18-Labeled L-Rhamnose Derivatives
Xiang Zhang, Falguni Basuli, Zhendan Shi, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3773-3773
Open Access
Xiang Zhang, Falguni Basuli, Zhendan Shi, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3773-3773
Open Access
Imaging Correlates of Immune Checkpoint Inhibitors in Cancer Management
Hanie Karimi, Soha Mohammadi, Parya Valizadeh, et al.
(2023), pp. 1-30
Closed Access
Hanie Karimi, Soha Mohammadi, Parya Valizadeh, et al.
(2023), pp. 1-30
Closed Access